Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
28 hedge funds and large institutions have $26.8M invested in Global Cord Blood Corporation in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 28 → 28 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0% less capital invested
Capital invested by funds: $26.9M → $26.8M (-$49.5K)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
88% less call options, than puts
Call options by funds: $5K | Put options by funds: $41K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
+$54.2K |
| 2 |
Simplex Trading
Chicago,
Illinois
|
+$33.1K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$31.6K |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$9.07K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$498K |
| 2 |
Renaissance Technologies
New York
|
-$332K |
| 3 |
PI
PEAK6 Investments
Chicago,
Illinois
|
-$183K |
| 4 |
MWA
Marshall Wace Asia
Central,
Hong Kong
|
-$165K |
| 5 |
BlackRock
New York
|
-$145K |
CO Hedge Fund Activity: Q4 2020 in Review
28 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q4 2020, worth a combined $26.8M — down 0.18% from $26.9M a quarter earlier.
Fund positioning in CO was balanced in Q4 2020: 3 funds opened new positions, 3 closed out, 8 added to existing stakes and 9 trimmed.
The largest buyer was Squarepoint, opening a new position worth an estimated $54.2K. The largest seller was Rock Springs Capital Management, cutting an estimated $498K.
- 28 institutional investors held Global Cord Blood Corporation (CO) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $26.8M of Global Cord Blood Corporation stock for Q4 2020, down 0.18% quarter-over-quarter.
- 3 funds opened new Global Cord Blood Corporation positions in Q4 2020 and 3 closed out, a net change of 0 holders.
- The largest Global Cord Blood Corporation buyer in Q4 2020 was Squarepoint, an estimated $54.2K added.
- The largest Global Cord Blood Corporation seller in Q4 2020 was Rock Springs Capital Management, an estimated $498K sold.
Based on aggregated 13F filings for Q4 2020.